Pfizer, Inc. (PFE) Tops Q2 EPS by 8c; Reaffirms Outlook; to File IPO for Animal Health Unit
Tweet Send to a Friend
Pfizer, Inc. (NYSE: PFE) reported Q2 EPS of $0.62, $0.08 better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
